Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Seizures
Interventions
DRUG

Levetiracetam

750 mg tablet

Trial Locations (1)

85044

MDS Pharma Services, Phoenix

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00826865 - Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter